- Magellan Aerospace reported 2nd Quarter revenue of C$249.8 million, marking a 2.8% year-over-year increase.
- The revenue fell short of the estimated C$260.5 million based on two analyst estimates.
- Reported EPS (Earnings Per Share) was C$0.090, compared to C$0.13 from the same quarter last year.
- This EPS figure was below the forecasted C$0.22 from two analysts.
- Adjusted EBITDA was C$21.1 million, a 3.6% decrease compared to the previous year.
- Investment sentiment on Magellan Aerospace is mixed with 1 buy rating, 0 hold ratings, and 1 sell rating from analysts.
A look at Magellan Aerospace Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 2 | |
| Growth | 5 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores for Magellan Aerospace, the company’s long-term outlook appears promising. With a high Growth score of 5, Magellan Aerospace is expected to experience significant expansion and development in the future. This suggests that the company is well-positioned to capitalize on opportunities for growth within the aerospace industry.
Additionally, Magellan Aerospace scores well in Value and Momentum, indicating a solid financial standing and positive market momentum. While the Dividend and Resilience scores are slightly lower, the overall outlook for Magellan Aerospace remains positive. As a supplier to both commercial and defense aircraft manufacturers, with a focus on advanced technologies such as radar, sonar, and satellite structures, Magellan Aerospace is poised to continue its path of innovation and success in the aerospace sector.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
